Daniel Lednicer, PhD, is the author of several books on drug synthesis and discovery. His career in both the private and public sectors has been devoted to the search for new therapeutic agents. Dr. Lednicer spent two decades at the bench as a chemist at the Upjohn Company. Following that, he served as director of chemical research at Mead Johnson, director of pharmaceutical sciences at Adria Laboratories, and pharmaceutical manager at Analytical Biochemistry Laboratories. Most recently, he was a project officer at the National Cancer Institute.

• Acyclic and Alicyclic Compounds. Monocyclic Aromatic Compounds. Polycyclic Aromatic and Hydroaromatic Compounds. Steroids. Five-Membered Heterocycles. Six-Membered Heterocycles. Five-Membered Benzoheterocycles. Six- and Seven-Membered Benzoheterocycles. Bicyclic Fused Heterocycles. Beta Lactams. Miscellaneous Fused Heterocycles. Indexes.